Hemostatics Concept

subject area of

• A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients  Academic Article
• A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME)  Academic Article
• A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose  Academic Article
• A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins  Academic Article
• A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery  Academic Article
• APPLICATION OF NOVEL HEMOSTATIC AGENT DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY  Academic Article
• Acute management of bleeding in patients on novel oral anticoagulants  Academic Article
• Acute reversal of anticoagulant-induced bleeding complications.  Academic Article
• Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis  Academic Article
• Bleeding and antidotes in new oral anticoagulants  Academic Article
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Academic Article
• Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review  Academic Article
• Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?  Academic Article
• Comparison of single subject and population‐based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A  Academic Article
• Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII  Academic Article
• DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature  Academic Article
• Effect of desmopressin on hematoma expansion in antiplatelet-associated intracerebral hemorrhage: A systematic review and meta-analysis  Academic Article
• Effects of Cathepsin G Pretreatment of Platelets on their Subsequent Responses to Aggregating Agents  Academic Article
• Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review  Academic Article
• Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor  Academic Article
• Feasibility of Using Recombinant Factor VIIa in Continuous Infusion  Academic Article
• Fibrin Sealant in Surgery of Patients with a Hemorrhagic Diathesis  Conference Paper
• Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis  Academic Article
• Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors  Academic Article
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Academic Article
• Haemostatic and replacement therapy in von Willebrand disease  Academic Article
• Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study  Academic Article
• How I treat target-specific oral anticoagulant–associated bleeding  Academic Article
• Identification of hemostatic markers that define the pre‐DIC state: A multi‐center observational study  Academic Article
• Immune Responses Associated With Perioperative Exposure and Reexposure to Topical Bovine Thrombin Do Not Impair Hemostasis  Academic Article
• Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial  Academic Article
• Management of Inheritedvon Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients  Academic Article
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Academic Article
• Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH  Academic Article
• Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents  Conference Paper
• Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada  Academic Article
• Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding  Academic Article
• NXY-059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Phase I Study  Academic Article
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conference Paper
• New method for packing the external auditory canal, middle ear space, and mastoid cavities after otologic surgery  Academic Article
• Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report)  Academic Article
• Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders  Academic Article
• Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH  Academic Article
• Plasma-derived biological medicines used to promote haemostasis  Academic Article
• Platelet substitutes.  Academic Article
• Pre-Procedure Desmopressin Acetate to Reduce Bleeding in Renal Failure: Does It Really Work?  Academic Article
• Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials.  Academic Article
• Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study  Academic Article
• Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial)  Academic Article
• Randomized Study of Aprotinin Effect on Transfusions and Blood Loss in Primary THA  Academic Article
• Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis  Academic Article
• Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse  Academic Article
• Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent  Academic Article
• Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference  Academic Article
• Recurrence of Dialysis Shunt Pseudoaneurysm Following Percutaneous Thrombin Embolization  Academic Article
• Retention of hemostatic and immunological properties of frozen plasma and COVID‐19 convalescent apheresis fresh‐frozen plasma produced and freeze‐dried in Canada  Academic Article
• Reversal of novel oral anticoagulants in patients with major bleeding  Academic Article
• Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1  Academic Article
• Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates  Academic Article
• The temporal changes of hemostatic activity in hospitalized patients with COVID-19: a prospective observational study  Academic Article
• The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A  Academic Article
• There may be no differences in the success of periapical surgery when using aluminum chloride or epinephrine as hemostatic agent during surgery  Academic Article
• There seem to be no differences in the hemostatic efficacy between aluminum chloride and electrocauterization in patients undergoing periapical surgery  Academic Article
• Thromboelastometry reveals similar hemostatic properties of purified fibrinogen and a mixture of purified cryoprecipitate protein components  Academic Article
• Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial  Academic Article
• Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis  Academic Article
• Understanding FVIII/VWF complex - report from a symposium of XXIX WFH meeting 2010  Academic Article
• Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A  Academic Article
• What can ex vivo experiments contribute to clinical haemostasis management?  Academic Article
• [New preparations for coagulation disorders].  Academic Article